Lilian Hunt

Lilian Hunt

Auto-generated profile, based on publicly available information

Lilian Hunt

Wellcome Trust

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2016 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
IRIlaria Dalla Rosa
Ilaria Dalla Rosa
YCYolanda Cámara
Yolanda Cámara
RDRomina Durigon
Romina Durigon
CMChloe F Moss
Chloe F Moss
SVSara Vidoni
Sara Vidoni
ASAntonella Spinazzola
Antonella Spinazzola
MPV17 is a mitochondrial inner membrane protein whose dysfunction causes mitochondrial DNA abnormalities and disease by an unknown mechanism. Perturbations of deoxynucleoside triphosphate (dNTP) pools are a recognized cause of mitochondrial genomic instability; therefore, we determined DNA copy number and dNTP levels in mitochondria of two models of MPV17 deficiency. In Mpv17 ablated mice, liver mitochondria showed substantial decreases in the levels of dGTP and dTTP and severe mitochondrial DNA depletion, whereas the dNTP pool was not significantly altered in kidney and brain mitochondria that had near normal levels of DNA. The shortage of mitochondrial dNTPs in Mpv17-/- liver slows the DNA replication in the organelle, as evidenced by the elevated level of replication intermediates. Quiescent fibroblasts of MPV17-mutant patients recapitulate key features of the primary affected tissue of the Mpv17-/- mice, displaying virtual absence of the protein, decreased dNTP levels and mitochondrial DNA depletion. Notably, the mitochondrial DNA loss in the patients’ quiescent fibroblasts was prevented and rescued by deoxynucleoside supplementation. Thus, our study establishes dNTP insufficiency in the mitochondria as the cause of mitochondrial DNA depletion in MPV17 deficiency, and identifies deoxynucleoside supplementation as a potential therapeutic strategy for MPV17-related disease. Moreover, changes in the expression of factors involved in mitochondrial deoxynucleotide homeostasis indicate a remodeling of nucleotide metabolism in MPV17 disease models, which suggests mitochondria lacking functional MPV17 have a restricted purine mitochondrial salvage pathway. Mitochondrial DNA depletion syndrome (MDS) is a genetically heterogeneous condition characterized by a decrease of mitochondrial DNA (mtDNA) copy number and decreased activities of respiratory chain enzymes. Depletion of mtDNA has been associated with mutations in several genes, which encode either proteins directly involved in mtDNA replication or factors regulating the homeostasis of the mitochondrial deoxynucleotide pool. However, for some genes the mechanism linking mutations and mtDNA depletion is not known. One such gene is MPV17, whose loss-of-function causes mtDNA abnormalities in human, mouse and yeast. Here we show that MPV17 dysfunction leads to a shortage of the precursors for DNA synthesis in the mitochondria, slowing DNA replication in the organelle. Not only does mtDNA copy number correlate with dNTP pool size in both mouse tissues and human cells, deoxynucleoside supplementation of the growth medium prevents depletion and restores mtDNA copy number in quiescent MPV17-deficient cells. Hence, our study links MPV17 deficiency, insufficiency of mitochondrial dNTPs, and slow replication in mitochondria to depletion of mtDNA manifesting in the human disease, and places MPV17-related disease firmly in the category of mtDNA disorders caused by deoxynucleotide perturbation. The prevention and reversal of mtDNA loss in MPV17 patient-derived cells identifies potential therapeutic strategy for a currently untreatable disease.

18 February 2022 in eLife
Verified
Journal Article
Open access
Manuel SpitschanManuel Spitschan
Manuel Spitschan
Nayantara SanthiNayantara Santhi
Nayantara Santhi
AAAmrita AHLUWALIA
Amrita AHLUWALIA
DFDorothee Fischer
Dorothee Fischer
LHLilian Hunt
Lilian Hunt
RWRhiannon White
Rhiannon White
Growing evidence shows that sex differences impact many facets of human biology. Here we review and discuss the impact of sex on human circadian and sleep physiology, and we uncover a data gap in the field investigating the non-visual effects of light in humans. A virtual workshop on the biomedical implications of sex differences in sleep and circadian physiology led to the following imperatives for future research: i) design research to be inclusive and accessible; ii) implement recruitment strategies that lead to a sex-balanced sample; iii) use data visualization to grasp the effect of sex; iv) implement statistical analyses that include sex as a factor and/or perform group analyses by sex, where possible; v) make participant-level data open and available to facilitate future meta-analytic efforts.

22 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
NKNatasha A. Karp
Natasha A. Karp
MBManuel Berdoy
Manuel Berdoy
KGKelly Gray
Kelly Gray
LHLilian Hunt
Lilian Hunt
MJMaggy Jennings
Maggy Jennings
LWLucy Whitfield
Lucy Whitfield
An interactive Sex Inclusive Research Framework (SIRF) supports the evaluation of in vivo and ex vivo research proposals to address the risk of sex bias in preclinical research. The framework delivers a traffic light classification, indicating whether a proposal is appropriate, risky, or insufficient with regard to sex inclusion. This tool is designed for use by researchers, (animal) ethical review boards, and funders to generate a rigorous and reproducible assessment of sex inclusion at the proposal level, thus helping address and resolve the embedded sex bias in preclinical research.

7 December 2015 in Genome Medicine
Verified
Journal Article
Open access
PDF file
LHLilian E. Hunt
Lilian E. Hunt
BNBoris Noyvert
Boris Noyvert
LBLeena Bhaw-Rosun
Leena Bhaw-Rosun
ASAbdul K. Sesay
Abdul K. Sesay
LPLavinia Paternoster
Lavinia Paternoster
GEGreg Elgar
Greg Elgar
Association studies have identified a number of loci that contribute to an increased body mass index (BMI), the strongest of which is in the first intron of the FTO gene on human chromosome 16q12.2. However, this region is both non-coding and under strong linkage disequilibrium, making it recalcitrant to functional interpretation. Furthermore, the FTO gene is located within a complex cis-regulatory landscape defined by a topologically associated domain that includes the IRXB gene cluster, a trio of developmental regulators. Consequently, at least three genes in this interval have been implicated in the aetiology of obesity. Here, we sequence a 2 Mb region encompassing the FTO, RPGRIP1L and IRXB cluster genes in 284 individuals from a well-characterised study group of Danish men containing extremely overweight young adults and controls. We further replicate our findings both in an expanded male cohort and an independent female study group. Finally, we compare our variant data with a previous study describing IRX3 and FTO interactions in this region. We obtain deep coverage across the entire region, allowing accurate and unequivocal determination of almost every single nucleotide polymorphism and short insertion/deletion. As well as confirming previous findings across the interval, we identify a further novel age-dependent association upstream of IRX5 that imposes a similar burden on BMI to the FTO locus. Our findings are consistent with the hypothesis that chromatin architectures play a role in regulating gene expression levels across topological domains while our targeted sequence approach represents a widely applicable methodology for high-resolution analysis of regional variation across candidate genomic loci.

16 December 2021 in OSF Preprints
Verified
Preprint
Open access
LHLilian Elizabeth Hunt
Lilian Elizabeth Hunt
LSLonda Schiebinger
Londa Schiebinger
National research agencies are responsible for promoting excellent research that benefits all of society (1). Integrating sex, gender, and diversity analysis (SG&DA) into the design of research, where relevant, can improve research methodology, enhance excellence in science, and make research more responsive to social needs (2). National funding agencies—encouraged by scientists and social movements—have thus begun to implement policies to integrate sex, gender, and, more recently, diversity analysis into the grant proposal process, where these factors have been shown to play a role. We develop a five-part analytical framework for implementing and evaluating SG&DA policies, and use it to evaluate the quality of SG&DA policies for 22 major national funding agencies across six continents. By collecting emerging global practices for policy implementation, we seek to improve understanding of these policies and practices in efforts to enhance international collaborations and research excellence.

6 October 2023 in OSF Preprints
Verified
Preprint
Open access
NKNatasha A Karp
Natasha A Karp
MBManuel Berdoy
Manuel Berdoy
LHLilian Elizabeth Hunt
Lilian Elizabeth Hunt
MJMaggy Jennings
Maggy Jennings
AKAngela Kerton
Angela Kerton
LWLucy Whitfield
Lucy Whitfield
A new, interactive framework supports the evaluation of in vivo and ex vivo research proposals from a sex inclusive research perspective delivering a traffic light classification, indicating whether a proposal is appropriate, risky, or insufficient with regards to sex inclusion. This tool is designed for use by researchers, (animal) ethical review boards, and funders to generate a rigorous and reproducible assessment of sex inclusion at the proposal level, thus helping address the embedded sex bias in preclinical research.